Starpharma Holdings Limited
SPHRF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $44,478 | $46,905 | $41,646 | $65,967 |
| - Cash | $15,407 | $20,277 | $23,360 | $32,131 |
| + Debt | $2,402 | $2,475 | $3,528 | $3,129 |
| Enterprise Value | $31,473 | $29,103 | $21,814 | $36,965 |
| Revenue | $3,423 | $2,427 | $1,731 | $7,197 |
| % Growth | 41% | 40.2% | -75.9% | – |
| Gross Profit | -$1,471 | -$2,258 | -$3,490 | $6,427 |
| % Margin | -43% | -93% | -201.6% | 89.3% |
| EBITDA | -$4,469 | -$5,254 | -$6,983 | -$2,649 |
| % Margin | -130.6% | -216.5% | -403.4% | -36.8% |
| Net Income | -$4,598 | -$5,392 | -$7,131 | -$1,034 |
| % Margin | -134.3% | -222.2% | -412% | -14.4% |
| EPS Diluted | -0.011 | -0.013 | -0.017 | -0.003 |
| % Growth | 15.4% | 24.9% | -592% | – |
| Operating Cash Flow | -$4,763 | -$1,996 | -$9,075 | $2,098 |
| Capital Expenditures | -$11 | -$31 | -$80 | -$9 |
| Free Cash Flow | -$4,774 | -$2,027 | -$9,155 | $2,089 |